AstraZeneca PLC ADR Underperforms Tuesday When Compared To Competitors
I'm PortAI, I can summarize articles.
AstraZeneca PLC ADR (AZN) fell 4.71% to $89.94 on Tuesday, underperforming compared to competitors like Eli Lilly & Co. and Biogen Inc. The NASDAQ Composite Index dropped 2.39%, while AstraZeneca's stock closed 6.81% below its 52-week high of $96.51. Trading volume reached 11.1 million, surpassing the 50-day average of 6.5 million. This trading session was challenging for the overall stock market, with the Dow Jones Industrial Average also declining by 1.76%.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Dow Jones The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments